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Abstract
Background: Men who have sex with men (MSM) globally have a high burden of curable sexually transmitted
infections (STIs). MSM do not frequently receive rectal STI testing because of several barriers, such as not being out
(disclosure of sexual behavior). We evaluate whether Chinese MSM select an STI test (rectal vs urethral) appropriate
for their sexual behavior (insertive and/or receptive), and the interactions with being out.
Methods: This was a secondary analysis of data from a cross sectional MSM survey conducted at a multisite
randomized controlled trial (RCT) (December 2018 to January 2019) around uptake of gonorrhea and chlamydia
testing among Chinese MSM (N = 431). We collected socio demographics, relevant medical and sexual history, and
disclosure of sexual behavior (outness). We estimated the decision to test and test choice, and the extent to which
disclosure plays a role in decision making.
Results: Among 431 MSM, mean age was 28 years (SD = 7.10) and 65% were out to someone. MSM who indicated
versatile sexual behavior and were out to someone had a 26.8% (95%CI = 6.1, 47.5) increased likelihood for selecting
the rectal test vs the ure thral test, compared to those versatile and not out. Versatile MSM out to their health
provider outside of the study context had a 29.4% (95%CI = 6.3, 52.6) greater likelihood for selecting the rectal STI
test vs the urethral test, compared to versatile MSM not out to their health provider.
Conclusions: Sexual behavior and outness may affect gonorrhea and chlamydia testing provision. Apart from
clinicians, community based efforts may reduce stigma based barriers to testing.
Keywords: MSM, Sexual health, Sexual behavior disclosure, China
Background
Men who have sex with men (MSM) globally have a
high burden of curable sexuall transmitted infections
(STIs) [1]. The World Health Organization (WHO) esti-
mates that there are annually 131 million and 78 million
new cases of Chlamydia trachomatis and Neisseria
gonorrhoeae, respectively [2]. Among MSM worldwide,
gonorrhea and chlamydia are the two most common
bacterial STIs [3]. The WHO recommends MSM receive
regular gonorrhoea and chlamydia testing [4].
The risk of contracting STIs can vary with sexual be-
haviors [5]. There are a variety of ways MSM engage in
intercourse, some related to preference and some not.
Sometimes the reason for sexual positioning is strategic
e.g. seropostioning [6, 7]. Some MSM prefer to engage
in receptive anal intercourse (top), others prefer insertive
anal intercourse (bottom) and some enjoy all types of
intercourse (versatile) [8, 9]. A preference for receptive
anal intercourse is associated with increased likelihood
of a gonorrhea and chlamydia infection [5]. MSM do not
frequently receive rectal STI testing because of several
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barriers, including: stigma, shame, fear of invasive sam-
pling, confidentiality concerns and clinician’s time pres-
sures [10]. Thus, both clinician and patient factors are
key to rectal STI testing. While clinician factors are im-
portant, we center on patient factors because: 1) Self
testing and self collection now allow rectal testing at
home, prior to seeing a clinician [11, 12]. We note that
self testing also happens in clinical settings [12].
Moreover, home based self testing has had several in-
novations, such as internet based testing which obviates
the need to see a clinician [13] and social entrepreneur-
ship models that promote self testing [14]; 2) Substantial
heterogeneity in MSM preferences may drive rectal test
uptake [15] along with a range of unaccounted factors
such as disclosure of sexual behavior (outness); 3) The
broader randomized controlled trial (RCT), from which
we drew data to conduct secondary analysis of a cross
sectional survey, provided a unique context where all
providers were offered rectal testing, allowing us to ob-
serve differences in MSM rectal STI uptake [16]. Within
these factors, the main barrier for testing is lack of dis-
closure [17, 18]. If MSM are unwilling to disclose their
sexual be havior, the likelihood of getting tested is low
[19]. We explore the relationship between outness and
rectal STI testing.
The objectives of the study were to assess if MSM are
more likely to select the gonorrhea and chlamydia test
most representative of their sexual behavior, compared
to a test less representative of their behavior; and if out-
ness is related to the decision to select a rectal vs ureth-
ral test. Research on MSM sexual behavior does not
often account for patient factors. Our study may shed
light on how sexual behavior and outness may affect
gonorrhea and chlamydia test provision, improving
MSM STI testing efforts.
Methods
Study design and participants
We conducted secondary analysis of baseline data from
a cross sectional survey collected through an RCT that
sought to improve on STI testing rates in MSM from
December 2018 January 2019 in China [20]. This RCT is
henceforth referred to the parent RCT, from which we
drew data to conduct secondary analysis to evaluate how
outness can affect STI test uptake. The parent RCT was
conducted in Guangzhou at two sites, and Beijing in a
single site. All RCT sites provided free HIV testing and
were administered by MSM community based organiza-
tions. Sites were selected based on MSM input, provided
free HIV and syphilis testing for MSM and had capacity
to deliver STI testing services during the study period.
All sites were staffed with a mix of MSM volunteers,
nurses, and public health staff, with no physicians. Blood
draws, testing, results reporting and test follow up were
handled by site based staff. Sites followed similar proce-
dures. Our inclusion criteria was that subjects were
assigned male sex at birth and identified as male, ≥ 16
years of age, reported anal intercourse with other men,
did not have a gonorrhea and chlamydia test in the past
year, did not previously participate in the study and were
willing to provide a mobile number or WeChat ID
(popular Chinese mobile application) for STI results no-
tification. The study was approved by the Human Sub-
jects Committee at the University of North Carolina at
Chapel Hill (IRB 18–2142), Southern Medical University
Dermatology Hospital (China) and Yale University. The
parent RCT [20] was registered on ClinicalTrials.gov
(NCT03741725). Written informed consent was ob-
tained from all participants.
Procedures
All testing sites offered gonorrhea and chlamydia tests
to MSM waiting for free HIV and syphilis testing. After
a short introduction to the gonorrhea and chlamydia
test, participants decided whether to receive testing.
After obtaining informed consent, we conducted patient
interviews (survey instrument in supplement) from all
men approached about a gonorrhea and chlamydia test,
even if they declined testing. We developed the survey
for study purposes. MSM were surveyed about their sex-
ual history, STI testing history, sexual behavior and
sociodemographic variables. MSM were offered gonor-
rhea and chlamydia tests and were given a choice to get
tested either at rectal or urethral sites but not both, be-
cause of limits to free testing at the clinics. While guide-
lines generally suggest triple site testing (urethral, rectal,
pharyngeal), [21, 22] this is not always possible in re-
source limited settings, such as our study. We thus pro-
vide implications generalizable to other resource-scarce
settings. With MSM limited to a single test, we have the
opportunity to understand the relationship between dis-
closure of sexual behavior and test choice. MSM were
told that the urethral test was appropriate for those pre-
ferring insertive anal intercourse, while the rectal test
was for those preferring receptive anal intercourse—
given that gonorrhea and chlamydia infections can be
site specific [23]. There was no unique choice specific to
versatile behavior. MSM could select to receive both
tests but would have to pay 150RMB (USD 21). Men
were told that their information would be kept confiden-
tial and gonorrhea and chlamydia test results sent after a
week. Program organizers updated respondents of test
results through WeChat. HIV, syphilis and gonorrhea
and chlamydia tests were conducted in the clinic and the
results recorded. Participants with positive test results
were counselled and directed to hospital resources to re-
ceive paid treatment and follow up care.
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Due to resource limitations, we were not able to
pay for participant treatment, but note that Chinese
STI treatment is relatively affordable [24]. These tests
would likely not have been done if the study had not
happened, as Chinese MSM have low gonorrhea and
chlamydia testing rates [15]. Our parent RCT in-
creased gonorrhea and chlamydia testing rates and re-
duced cost, with the control being the community
standard of care [20].
The question on disclosure was as follows:” In the
past, have you told anyone about your sexuality or sex-
ual history with men?” The following options were pro-
vided: (1)” Yes, my long term female partner/wife”; (2)”
Yes, my family members”; (3)” Yes, my friends”; (4)” Yes,
my healthcare providers”; (5)” No one”. Options four
and five were coded as binary variables to detail sexual
behavior disclosure to health providers and non-specific
disclosure respectively. Option five captures disclosure
in a non-specific sense i.e. anyone and is associated with
improved health outcomes [25, 26]. Option four indi-
cates disclosure to health providers, which is key to re-
ceiving appropriate healthcare [27], more so than the
other group specific disclosure options. For example,
men out to their healthcare provider are more likely to
get HIV testing compared to those out to their family
[28]. Although participants attended a specialized
MSM testing clinic, this does not reflect their disclos-
ure to their primary care or other health providers.
There is significant stigma around MSM sexual be-
havior in China [29] and thus men may be comfort-
able going to an MSM centric health provider, yet
not be out to their primary health provider. For ex-
ample, while men were out within the context of the
health clinic in the study, 35% were not out to any-
one and 80% were not out to their primary health
provider. Given the high rates of non-disclosure out-
side the testing clinic, we suggest137 that broader
non-disclosure may affect in study outcomes.
Statistical analysis
To analyze study data we used inferential statistical
methods. First, a probit model with sample selection
was used to assess the relationship between receiving
a rectal STI test and various sexual behaviors (recep-
tive, insertive, versatile). Then, we used a probit
model with sample selection to assess the relationship
between receiving a rectal STI and sexual behavior
disclosure/outness (non-specific disclosure, disclosure
to health provider). We used STATA 13.0 [30]. All
models included demographics, socioeconomic mea-
sures and sexual history as controls. Further informa-
tion about statistical methods is in supplement.
P < 0.05 was considered significant.
Results
We approached 431 men intending to test for HIV and
syphilis. After exclusion criteria and decision to partici-
pate, 301 men were enrolled and STI test uptake was
40%. Seven men chose to get both tests and were
dropped from the analysis. As we are exploring whether
sexual behavior is related to the choice of rectal over ur-
ethral testing, those who took both tests were not a
focus of our analysis. Forty four % (50/114) chose the
rectal gonorrhea and chlamydia test and 56% (64/114)
picked the urethral gonorrhea and chlamydia test.
Among the RCT participants, 35% (187/288) had dis-
closed sexual behavior to someone (non -specific dis-
closure) and 21% (59/288) of men had disclosed sexual
behavior to their health provider. Five MSM were diag-
nosed with gonorrhea (urethral two, rectal three) and 19
with chlamydia (urethral six, rectal 13). We present de-
scriptive statistics in Table 1.
Using three separate models, we explored if MSM
made a test choice in line with their indicated sexual be-
havior. Table 2 indicated that receptive sexual behavior
was associated with 45.2% (95%CI = 33.8, 56.5) increased
likelihood for selecting a rectal test.
Insertive sexual behavior was related to 51.1%
(95%CI = -58.7, − 43.5) decreased likelihood for selecting
the rectal test. Finally, versatile sexual behavior was not
significantly associated with selecting a rectal test, pos-
sibly indicating that versatile MSM have no preference
for a rectal gonorrhea and chlamydia test.
We then explored disclosure and likelihood to select the
rectal gonorrhea and chlamydia test. Table 3 indicated that
there was no significant relationship between non-specific
disclosure or disclosure to one’s health provider, and select-
ing a rectal gonorrhea and chlamydia test. Table 4 indicated
that, for versatile MSM, non-specific disclosure was associ-
ated with a 26.8% (95%CI = 6.1, 47.5) increased likelihood of
selecting the rectal gonorrhea and chlamydia test compared
to the urethral test. We also found that for versatile MSM,
disclosure to one’s health provider was associated with a
29.4% (95%CI = 6.3, 52.6) greater likelihood for selecting the
rectal gonorrhea and chlamydia test, compared to the ureth-
ral test. These results were visualized in Fig. 1, focusing on
the interaction effects between disclosure and versatile sexual
behavior. While being versatile alone was not significantly as-
sociated with rectal test uptake, once non-specific disclosure
or disclosure to health providers comes into the picture, the
model suggested a large and significant increase in rectal test
uptake. Note that this was a marginal effect, controlling for
sociodemographics, sexual history and medical history rele-
vant to STI testing.
Discussion
We first demonstrated that MSM selected tests in line
with their preferred sexual behavior. We then indicated
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that versatile MSM out to a non-specific individual or
one’s health provider (outside the study context) had in-
creased likelihood for selecting the rectal gonorrhea and
chlamydia test, compared to the urethral test. Our find-
ings190 are in line with past research and reinforce the
need to screen MSM for STIs through a full scope of
transmission routes, ensuring no STIs are undiagnosed.
We detailed how patient factors such as sexual behavior
and outness may affect gonorrhea and chlamydia193 test
provision in a clinical setting.
Many MSM in our sample with indications for rectal
STI testing did not receive it. This is consistent with re-
search in China and globally. A China based study found
a higher prevalence of rectal chlamydia infection (24.4%)
compared to urethral infection (5.3%) [31]. Similar find-
ings were indicated in several other studies, where rectal
prevalence of STIs was greater than the urethral preva-
lence [32–34]. Other global studies indicated similar
findings. Among asymptomatic men screened for chla-
mydia, 9.8% were positive for rectal infection vs 2.3% for
a urethral infection. However, the same study reported
higher prevalence of urethral gonorrhea (5.0%) vs rectal
gonorrhea (3.0%) [22]. Other studies indicated higher
rates of rectal STI infections compared to urethral
infections [35, 36]. Rectal STIs were associated with an
increased risk for HIV seroconversion [37]. A retrospect-
ive MSM cohort study found that greater than two prior
rectal gonorrhea or chlamydia infections were associated
with eight times greater risk of HIV conversion [38].
Our findings indicated there could be a large number of
missed infections and underestimation of STI preva-
lence. Undetected and consequently untreated cases may
exacerbate the Chinese MSM STI epidemic [39]. We ex-
tended previous research suggesting the importance of
rectal STI testing in MSM. MSM in marginalized con-
texts and resource limited settings may need to receive a
combined rectal, urethral and pharyngeal gonorrhea and
Table 1 Participants characteristics
Variable Mean (SD)
Age 28.10 (7.10)
Number of male partners last three months 2.30 (2.98)
%
Gonorrhea test site
rectal 43.9
urethal 56.1
n = 114
Sexual behavior
receptive 31.8
insertive 37.8
versatile 30.4
n = 283
Yearly income, $
< 2690.88 11.5
2690.88–5381.64 9.0
5381.64–8969.40 14.9
8969.40–14,351.04 26.4
> 14,351.04 38.2
n = 288
Experienced STI symptoms
no 11.2
yes 88.8
n = 285
HIV test frequency
< once every two years 16.9
once a year 23.0
once every six months 28.1
once every three months 26.3
monthly 5.8
n = 278
Previous HIV test
no 9.0
yes 91.0
n = 288
Frequency of condomless anal intercourse last three months
0% condom use 6.0
< 50% condom use 10.3
> 50% condom use 29.5
100% condom use 54.3
n = 234
Out to someone (Non-specific disclosure)
no 35.1
yes 64.9
n = 288
Table 1 Participants characteristics (Continued)
Variable Mean (SD)
Out to health provider (Disclosure to health provider)
no 79.5
yes 20.5
n = 288
Gonorrhea test result
negative 98.3
positive 1.7
n = 114
Chlamydia test result
negative 93.7
positive 6.3
n = 114
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chlamydia test, as pharyngeal gonorrhea and chlamydia
testing is also recommended for MSM [40]. However,
when resources are scarce, as per our study, stigma free
settings may allow for providing a single test most ap-
propriate to sexual behavior.
Finally we found that MSM who had disclosed their
sexual behavior to someone (non-specific disclosure)
or their healthcare provider (outside the study con-
text) were more likely to select rectal STI testing
compared to urethral testing. Past China research in-
dicated that larger disclosure networks were associ-
ated with greater propensity of HIV testing [18, 28].
Increased probability of never testing for HIV or
syphilis was associated with non-disclosure to anyone
or health professionals [41, 42]. The odds of disclos-
ure to a healthcare professional was greater for MSM
who had received an STI or HIV test [43]. In global lit-
erature, disclosure to healthcare providers was associated
Table 2 Multivariate analyses of MSM propensity to select the rectal test compared to the urethral test, in line with sexual behavior
Variable Marginal Effects (95% CI) P Marginal Effects (95% CI) P Marginal Effects (95% CI)
Sexual behavior Receptive Insertive Versatile
Dependent variable: rectal test
Insertive – – − 0.51 (− 0.59, − 0.44) < .001 –
Receptive 0.45 (0.34, 0.57) < .001 – – –
Versatile – – – – 0.006 (− 0.18, 0.19)
Age 0.006 (− 0.001, 0.013) .12 0.004 (− 0.009, 0.018) .52 0.003 (− 0.012, 0.019)
Income 0.012 (− 0.036, 0.060) .64 0.050 (− 0.027, 0.128) .2 0.05 (− 0.05, 0.14)
Number of male partners last three months −0.022 (− 0.042, − 0.001) .04 −0.019 (− 0.035, − 0.002) .03 −0.01 (− 0.04, 0.01)
Frequency of condomless anal intercourse
last three months
0.12 (− 0.031, 0.28) .12 0.37 (0.17, 0.57) < .001 0.26 (−0.13, 0.65)
Non-specific disclosure −0.08 (− 0.19, 0.03) .16 − 0.093 (− 0.34, 0.15) .46 0.12 (− 0.1, 0.33)
Disclosure to health provider 0.04 (− 0.11, 0.18) .6 −0.041 (− 0.29, 0.20) .74 −0.046 (− 0.29, 0.20)
N 85 85 85
Predicted mean for receiving a rectal test 0.33 0.41 0.32
Note: Marginal effects of probit with sample selection (outcome equation results shown). Confidence interval (CI) estimated using jackknife with clustering by sites
and within-site groups. Receptive: Compared to MSM not indicating the receptive role, MSM indicating the receptive role are more likely to select the rectal
gonorrhea and chlamydia test, compared to the urethral test; Insertive: Compared to MSM not indicating the insertive role, MSM indicating the insertive role are
less likely to select the rectal gonorrhea and chlamydia test, compared to the urethral test; Versatile: Compared to MSM not indicating the versatile role, MSM
indicating the versatile role have no gonorrhea and chlamydia test preference
Table 3 Multivariate analyses of MSM propensity to select the rectal test compared to the urethral test, in line with non-specific
disclosure and disclosure to health provider
Variable Marginal Effects (95% CI) P Marginal Effects (95% CI) P
Type of disclosure Non-specific disclosure Disclosure to health provider
Dependent variable: rectal test
Insertive – – – –
Receptive 0.58 (0.5, 0.66) < .001 0.58 (0.53, 0.64) < .001
Versatile 0.26 (−0.23, 0.78) 0.29 0.26 (0.12, 0.41) < .001
Age 0.01 (−0.01, 0.02) .45 0.01 (−0.01, 0.02) .35
Income 0.03 (−0.04, 0.1) .47 0.02 (−0.04, 0.08) .54
Number of male partners last three months −0.02 (− 0.1, 0.05) .51 − 0.03 (− 0.06, 0.002) .07
Frequency of condomless anal intercourse last three months 0.23 (0.06, 0.4) .01 0.23 (0.1, 0.36) .001
Non-specific disclosure −0.08 (− 0.32, 0.15) .49 – –
Disclosure to health provider – – −0.04 (− 0.25, 0.17) .72
N 85 85
Predicted mean for receiving a rectal test 0.4 0.41
Note: Marginal effects of probit with sample selection (outcome equation results shown). Confidence interval (CI) estimated using jackknife with clustering by sites
and within-site groups. Non-specific disclosure: Compared to those not out to anyone, those out to someone are more likely to select the rectal gonorrhea and
chlamydia test, compared to the urethral test; Disclosure to health provider: Compared to those not out to their health provider, those out to their health provider
are more likely to select the rectal gonorrhea and chlamydia test, compared to the urethral test
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with HIV223 and STI testing among young MSM [44].
Closeted MSM were less likely to have tested for HIV
compared to out MSM [27, 45]. Being completely out or
even disclosure to a healthcare provider is clearly key to
receiving STI and HIV testing, as Chinese MSM often ex-
press fear of being ostracized because of their sexual be-
havior, a common barrier preventing testing [46]. When
MSM are given a choice between a rectal or urethral test,
it is possible that patient factors affect test selection
decision. We extend the literature to suggest that disclos-
ure can improve testing outcomes.
Limitations
This work has limitations. First, other unmeasured fac-
tors, such as knowledge levels about STIs and site of STI
symptom (urethral or rectal), may have driven selection
of the urethral gonorrhea and chlamydia test. We par-
tially addressed this by controlling for previous HIV test,
Table 4 Multivariate analyses of versatile MSM propensity to select the rectal test compared to the urethral test, in line with non-
specific disclosure and disclosure to health provider
Variable Marginal Effects (95% CI) P Marginal Effects (95% CI) P
Type of disclosure Non-specific disclosure Disclosure to health provider
Dependent variable: rectal test
Insertive – – – –
Receptive 0.61 (0.52, 0.70) < .001 0.56 (0.46, 0.67) < .001
Versatile 0.36 (0.23, 0.48) < .001 0.15 (0.03, 0.26) .01
Age 0.004 (−0.01, 0.01) .46 0.005 (0.001, 0.01) .01
Income 0.03 (−0.02, 0.08) .24 0.02 (−0.02, 0.05) .39
Number of male partners last three months −0.03 (− 0.06, 0.003) .08 − 0.03 (− 0.05, − 0.01) .01
Frequency of condomless anal intercourse last three months 0.2 (0.09, 0.32) .001 0.19 (0.05, 0.33) .01
Non-specific disclosure −0.2 (− 0.36, − 0.05) .01 – –
Versatile*non-specific disclosure 0.27 (0.06, 0.48) .01 – –
Disclosure to health provider – – −0.16 (− 0.29, − 0.04) .01
Versatile*disclosure to health provider – – 0.29 (0.06, 0.53) .01
N 85 85
Predicted mean for receiving a rectal test 0.41 0.39
Note: Marginal effects of probit with sample selection (outcome equation results shown). Confidence interval (CI) estimated using jackknife with clustering by sites
and within-site groups. Non-specific disclosure: Compared to versatile MSM not out to someone, versatile MSM who are out to someone (disclosed sexual
identity) are more likely to select the rectal gonorrhea and chlamydia test, compared to the urethral test; Disclosure to health provider: Compared to versatile
MSM not out to their health provider, versatile MSM out to their health provider are more likely to select the rectal gonorrhea and chlamydia test, compared to
the urethral test
Fig. 1 Probability of selecting a rectal gonorrhea and chlamydia test as a function of outness, for MSM preferring versatile sexual behavior.
(Predicted probabilities shown, based on marginal effects estimated by respective models (accounting for selection) and the population sample)
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HIV test frequency, and possible STI symptoms in esti-
mating the decision to test, but not the choice between
the tests (since these measures are not site specific). We
also conducted our analysis including education level as a
control, but excluded it from the final analysis due to near
colinearity with income. We did not consider how the
psychological effects of testing would affect results. STI
testing can be viewed as a form of commitment in a rela-
tionship [47] or cause significant distress [48].
Further work can model this through a survey item or
qualitative techniques. Second, the gonorrhea and chla-
mydia test RCT was conducted at sites catered to MSM
STI testing. Such site selection may have limited analysis
to MSM connected with community based organizations
and already interested in HIV testing [49]. Despite lim-
ited generalizability to hospitals and other provider set-
tings, our results remain relevant since specialized
community MSM clinics remain major providers of test-
ing in China [50] and globally [51] where patient factors
drive health outcomes. As participants would have to
pay an247 additional amount to take both tests, it could
be that some selected a single test due to lack of funds.
We utilized income as a control to account for this con-
cern. Due to resource limitations, we were unable to
offer rectal and urethral testing to all participants and
then determine the number of mismatches between a
positive test at a particular site and sexual behavior (e.g.
MSM reporting insertive sexual behavior but with a
positive2 rectal test). Future research will incorporate
such a study design.
Conclusion
Greater efforts are needed to ensure that patient factors
do not adversely affect MSM testing outcomes. Sexual be-
havior and outness may affect gonorrhea and chlamydia-
testing provision. Apart from clinicians, community based
efforts may reduce stigma based barriers to testing.
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